These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Application of oral hypoglycemic agents in the therapy of diabetes mellitus]. Toyota T Nihon Naika Gakkai Zasshi; 1991 Aug; 80(8):1205-9. PubMed ID: 1919237 [No Abstract] [Full Text] [Related]
7. Case report: treating type 2 diabetes. Using four oral hypoglycemic drugs. Lockman LE Can Fam Physician; 2003 Jun; 49():775-6. PubMed ID: 12836866 [No Abstract] [Full Text] [Related]
9. [Oral treatment of diabetes mellitus type 2. Limitations, perspectives]. Dumitrescu C; Găvănescu M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(1):71-7. PubMed ID: 2873647 [No Abstract] [Full Text] [Related]
10. New landscape of type 2 diabetes management. Kruger DF J Am Acad Nurse Pract; 2007; 19(11 Suppl 1):5-10. PubMed ID: 18341242 [No Abstract] [Full Text] [Related]
11. [Types and choice of the treatment in diabetes mellitus]. Goto Y; Abe R; Hori S Nihon Rinsho; 1990 Dec; 48 Suppl():803-9. PubMed ID: 2128349 [No Abstract] [Full Text] [Related]
12. Insulin therapy in type 2 diabetes. Wyne KL; Mora PF Endocr Res; 2007; 32(3):71-107. PubMed ID: 18092196 [No Abstract] [Full Text] [Related]
13. Treating type 2 diabetes: targeting the many causative factors. Sutherland JE; Hoehns JD J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823 [No Abstract] [Full Text] [Related]
14. [New oral antidiabetic agents and current strategies of peroral antidiabetic therapy (PAD)]. Rybka J; Kvapil M Vnitr Lek; 2002 Jun; 48(6):517-22. PubMed ID: 12132353 [TBL] [Abstract][Full Text] [Related]
15. [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease]. Nauck MA; Matthaei S Dtsch Med Wochenschr; 2005 Apr; 130(17):1091-6. PubMed ID: 15841424 [No Abstract] [Full Text] [Related]
16. Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255. Karalliedde J; Viberti GC Diabetes; 2007 May; 56(5):e3; author reply e4. PubMed ID: 17470560 [No Abstract] [Full Text] [Related]
17. Management of type 2 diabetes: oral agents, insulin, and injectables. Fonseca VA; Kulkarni KD J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251 [TBL] [Abstract][Full Text] [Related]
18. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [TBL] [Abstract][Full Text] [Related]